alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
# State Plans and Strategies - Appalachian Regional Commission

- New York Strategy Statement The post New York Strategy Statement appeared first on Appalachian Regional Commission.
- West Virginia Appalachian Development Plan The post West Virginia Appalachian Development Plan appeared first on Appalachian Regional Commission.
- Virginia Strategy Statement The post Virginia Strategy Statement appeared first on Appalachian Regional Commission.
- Virginia Appalachian Development Plan The post Virginia Appalachian Development Plan appeared first on Appalachian Regional Commission.
- Tennessee Strategy Statement The post Tennessee Strategy Statement appeared first on Appalachian Regional Commission.
- Tennessee Appalachian Development Plan The post Tennessee Appalachian Development Plan appeared first on Appalachian Regional Commission.
- South Carolina Appalachian Development Plan The post South Carolina Appalachian Development Plan appeared first on Appalachian Regional Commission.
- Pennsylvania Appalachian Development Plan The post Pennsylvania Appalachian Development Plan appeared first on Appalachian Regional Commission.
- Ohio Appalachian Development Plan The post Ohio Appalachian Development Plan appeared first on Appalachian Regional Commission.
- North Carolina Appalachian Development Plan The post North Carolina Appalachian Development Plan appeared first on Appalachian Regional Commission.
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
                          OF CORPORATE GENERAL PARTNER

            PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The undersigned, James M. Seneff, Jr., the Chief Executive Officer of CNL Realty
Corporation,  the corporate  general  partner of CNL Income Fund VIII, Ltd. (the
"Partnership"),  has executed this  certification  in connection with the filing
with the Securities and Exchange  Commission of the Partnership's  Annual Report
on Form  10-K for the  period  ending  December  31,  2002 (the  "Report").  The
undersigned hereby certifies that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of
the Securities Exchange Act of 1934; and

(2) the  information  contained in the Report fairly  presents,  in all material
respects, the financial condition and results of operations of the Partnership.



Date:    March 24, 2003                         /s/ James M. Seneff, Jr.
                                                ---------------------------
                                                Name:  James M. Seneff, Jr.
                                                Title: Chief Executive Officer
#### The People of the State of New York, Respondent, v Larry McReynolds, Appellant.

— Judgment of the Supreme Court, Bronx County (Joseph Mazur, J.), rendered on December 5, 1988, which convicted defendant of criminal sale of a controlled substance in the third degree, after a jury trial, and sentenced him to an indeterminate term of imprisonment of six to twelve years, unanimously reversed, on the law and the facts and as a matter of discretion in the interest of justice, and the matter is remanded for a new trial.

We reverse in the interest of justice because the prosecutor’s ad hominem remarks during summation, directed at defense counsel, so overstepped the bounds of permissible comment that appellant was denied a fair trial.

During summation, a prosecutor may respond to defense counsel’s summation, but it is improper to mischaracterize the defense and impugn the defense counsel’s integrity. *(People v Galloway,*54 NY2d 396, 398; *People v Matthews,*33 AD2d 679; *People v Ortiz,*116 AD2d 531 [1st Dept 1986].) Here, the prosecutor exceeded permissible bounds by calling the defense counsel’s arguments "worthless”, and vouching for his argument that the defense was a fabrication. At one point he *32stated, "There is a lot of fabrication going on in this courtroom but it is not coming from the witness stand, I swear to you.” Counsel’s integrity was not at issue, and it was, accordingly, highly inappropriate to urge that counsel was attempting to mislead the jury. *(People v Steinhardt,*9 NY2d 267, 271.) In light of the prosecutor’s comment that certain testimony went uncontradicted, he should not have offered his personal assurance that the testimony he produced was credible. *(People v Petrucelli,*44 AD2d 58.)

Based on the prosecutor’s improper summation, the appellant was denied his due process right to a fair trial.

Appellant’s motion to enlarge the record is denied as moot. Concur — Murphy, P. J., Wallach, Asch, Kassal and Smith, JJ.
2005 Incentive Plan



 Exhibit 10.3 
  
 CAPTARIS, INC. 
  
 2005 INCENTIVE PLAN 
  
 The 2005 Incentive Plan (the “Plan”) is a cash bonus plan in which the executive officers and certain other employees of Captaris, Inc. (the
“Company”) are eligible to participate. The Plan provides cash bonuses based on the achievement of goals related to the Company’s 2005 performance. 
  
 The Compensation Committee of the Company’s Board of Directors (the “Compensation Committee”) administers the
Plan. The Compensation Committee, in its sole discretion, establishes the performance goal or goals for each participant and the formulae used to determine the actual bonus (if any) payable to each participant under the Plan. The total amount of
funds available under the Plan and the cash target awards for the Company’s executive officers are established by the Compensation Committee. The other employees who participate in the Plan and the cash target awards for other participants are
established by the Company’s management. 
  
 There are two
components to the Plan. The first component of the Plan links payout to achievement of performance goals related to revenue (30%), operating income (30%), operating cash (20%) and revenue diversification (20%). Depending on the level of achievement
for each goal, participants in the aggregate may receive between 0% and 150% of the target amount for each goal. The second component of the Plan links payout to achievement of performance goals related to revenue from the Alchemy product line and
cost savings associated with the integration of Information Management Research, Inc. Depending on the level of achievement for these goals, the participants in the aggregate may receive between 0% and 100% of the target amount for this component of
the Plan. 
  
 The Compensation Committee, in its sole discretion,
may (a) eliminate, increase or reduce the bonus payable to any participant above or below that which otherwise would be payable under the payout formula, (b) determine whether or not any bonus will be paid in the event of a participant’s
termination of service prior to the end of the performance period and (c) modify or terminate the Plan at any time. 
  
 Payment of bonuses, if any, under the Plan shall be made as soon as practicable after the end of the performance period during which the bonus was earned.
Each bonus shall be paid in cash in a single lump sum, subject to payroll taxes and tax withholding. 
  
 Each bonus that may become payable under the Plan shall be paid solely from the general assets of the Company. Nothing in the Plan should be construed to
create a trust or to establish or evidence any participant’s claim of any right to payment of a bonus other than as an unsecured general creditor with respect to any payment to which a participant may be entitled.
WARNING: THE EDGAR SYSTEM ENCOUNTERED ERROR(S) WHILE PROCESSING THIS SCHEDULE.

<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     This schedule  contains summary  financial  information  extracted from the
Consolidated  Statement  of  Financial  Condition  at December  31, 1996 and the
Consolidated Statement of Operations for the Year Ended December 31, 1996 and is
qualified in its entirety by reference to such financial statements.
</LEGEND>
<CIK>                         0000908531
<MULTIPLIER>                  1,000

<S>                           <C>
<PERIOD-TYPE>                 12-MOS
<FISCAL-YEAR-END>                              DEC-31-1996
<PERIOD-START>                                 JAN-01-1996
<PERIOD-END>                                   DEC-31-1996
<CASH>                                              15,490
<SECURITIES>                                             0
<RECEIVABLES>                                        1,621
<ALLOWANCES>                                           345
<INVENTORY>                                          1,198
<CURRENT-ASSETS>                                    20,584
<PP&E>                                             201,855
<DEPRECIATION>                                      28,736
<TOTAL-ASSETS>                                     223,718
<CURRENT-LIABILITIES>                               19,892
<BONDS>                                            181,081
<PREFERRED-MANDATORY>                               16,430
<PREFERRED>                                              0
<COMMON>                                                29
<OTHER-SE>                                           6,286
<TOTAL-LIABILITY-AND-EQUITY>                       223,718
<SALES>                                            161,707
<TOTAL-REVENUES>                                   174,234
<CGS>                                               65,941
<TOTAL-COSTS>                                       65,941
<OTHER-EXPENSES>                                    69,143
<LOSS-PROVISION>                                       194
<INTEREST-EXPENSE>                                  22,170
<INCOME-PRETAX>                                      6,208
<INCOME-TAX>                                            69
<INCOME-CONTINUING>                                  6,139
<DISCONTINUED>                                           0
<EXTRAORDINARY>                                          0
<CHANGES>                                                0
<NET-INCOME>                                         6,139
<EPS-PRIMARY>                                          .15
<EPS-DILUTED>                                          .15



</TABLE>
```

[Congressional Record Volume 158, Number 117 (Thursday, August 2, 2012)]
[House]
[Page H5686]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

                     WHAT THE AMERICAN PEOPLE WANT

  (Ms. PELOSI asked and was given permission to address the House for 1 
minute.)
  Ms. PELOSI. Mr. Speaker, this Republican majority is prepared to 
adjourn the House of Representatives to leave for the August district 
work period without accomplishing what the American people have sent us 
here to do. They want us to create jobs. They want us to reduce the 
deficit, and they want us to give a middle-income tax cut, which the 
President has suggested and the American people overwhelmingly support.
  Instead, we have no jobs agenda, no tax cuts for the middle class, no 
farm bill, no Violence Against Women Act, no cybersecurity strategy, no 
balanced, bipartisan plan to prevent the sequester.
  The only thing the Republicans have done is to increase the 
uncertainty that threatens another debt crisis and undermines our 
economic growth. Now they want to head out of town to campaign, when 
Congress should stay in session to address the most pressing challenges 
facing our Nation: job creation, growth in our economy, and 
strengthening the middle class.
  Mr. Speaker, Democrats want us to get our job done. When we go home 
to meet with our constituents, we want to say what we have accomplished 
and what results we can bring that have been worked out in a fair, 
bipartisan, balanced way.
  In spite of this, the Republican obstruction at every turn is 
preventing that.
  Let's get to work. Let's do the job our constituents elected us to 
do: to create jobs with them and to relieve the uncertainty in their 
lives.

                          ____________________
```
Anastrepha ludens, Mexican Fruit Fly Host List, July 2021

(Excerpted from Federal Order DA-2021-17, July 14, 2021)

The berry, fruit, nut, or vegetable of the following plant species are now considered regulated 

(host) articles for Mexican fruit fly and are subject to the requirements of 7 CFR 301.32. In 

addition, all varieties, subspecies and hybrids of the regulated articles listed are assumed to be 

suitable hosts unless proven otherwise.

Scientific Name1 Common Name

Anacardium occidentale L. Cashew nut

Annona cherimola Mill. Cherimoya, custard-apple

Annona cherimola Mill. × Annona reticulata L. Atemoya

Annona liebmanniana Baill. Hardshell custard-apple

Annona reticulata L. Custard-apple

Annona squamosa L. Sugar apple

Carica papaya L. Papaya

Casimiroa edulis La Llave & Lex. Mexican-apple, white sapote

Casimiroa greggii (S. Watson) F. Chiang Yellow chapote

Casimiroa sapota Oerst. Matasano

Citrus spp. Orangequat, procimequat

Citrus ×aurantiifolia (Christm.) Swingle Lime, Key lime, Mexican lime, 

sour lime, lima

Citrus ×aurantium L. Bitter orange, clementine, sour 

orange, tangelo

Citrus ×aurantium L. var. sinensis L. Blood orange, common orange, 

naval orange, sweet orange, 

orange, Valencia orange

Citrus deliciosa Ten. Mandarina, Italian tangerine

Citrus ×limon (L.) Osbeck Dwarf lemon, Canton lemon, 

Chinese dwarf lemon, Sweet 

lemon or lime, Red lemon, 

Meyer lemon

Citrus maxima (Burm.) Merr. Pomelo

Citrus medica L. Buddha’s-Hand, citron, finger 

citron

Citrus ×nobilis Lour. King orange, Mandarina, tangor

Citrus ×paradisi Macfad. Grapefruit, pomelo, toronja

Citrus reshni hort. ex Tan Cleopatra mandarin, mandarina, 

spice mandarin

Citrus reticulata Blanco Mandarin, Swatow orange, 

tangerine

Citrus unshiu Marcow Mandarin, Satsuma orange

Coffea arabica L. Coffee, Arabian coffee

Cydonia oblonga Mill. Quince, membrillo
Diospyros kaki Thunb. Oriental persimmon, Caqui, kaki

Inga inicuil Schltdl. & Cham. ex G. Don Ice cream bean, Algodoncillo, 

Chalahuite

Inga micheliana Harms Chalum

Malus domestica (Suckow) Borkh. Apple, Manzana

Malus pumila Mill. Paradise apple

Mammea americana L. Mamey, mammee-apple, 

tropical-apricot

Mangifera indica L. Mango

Melicoccus oliviformis Kunth Guaya

Passiflora edulis Sims Passionfruit, lilikoi, parcha, 

purple granadilla

Persea americana Mill. Avocado2

Prunus persica (L.) Batsch Durazno, peach

Psidium cattleyanum Sabine var. littorale

(Raddi) Fosberg

Strawberry guava, yellow guava

Psidium guajava L. Guava

Punica granatum L. Pomegranate

Pyrus communis L. Pear

Sideroxylon capiri (A. DC.) Pittier Danto amarillo

Sideroxylon capiri (A. DC.) Pittier subsp. 

tempisque (Pittier) T. D. Penn.

Danto amarillo, tempisque

Spondias purpurea L. Red and purple mombin, ovo, 

Spanish-plum, jocote

Syzygium jambos (L.) Alston Jambos, rose-apple, yambo

Terminalia catappa L. Tropical almond

1Host in BOLD are new to the list

2Fresh, mature green variety ‘Hass’ avocadoes are not regulated
**Exhibit 23.1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

 

We consent to the incorporation by reference in the following RegistrationStatements of Sky Financial Group, Inc. (the “Company”) of our reports dated February 16, 2005, relating to the consolidated financial statements of the Company and management’s report of the effectiveness of internal control overfinancial reporting, appearing in this Annual Report on Form 10-K of the Company for the year ended December 31, 2004. 

 

Form S-3 No. 333-117186 

Form S-8 No. 333-117185 

Form S-8 No. 333-117184 

Form S-8 No. 333-108810 

Form S-8 No. 333-65492 

Form S-8 No. 333-59312 

Form S-8 No. 333-67233 

Form S-8 No. 333-47315 (Post-Effective Amendment No.1on Form S-8 to Form S-4) 

Form S-8 No. 333-60741 (Post Effective Amendment No.1 on Form S-8 to Form S-4) 

Form S-3 No. 333-64127 

Form S-8 No. 333-18867 

 

/s/ Deloitte & Touche LLP 

 

Deloitte & Touche LLP 

Cleveland, Ohio 

February 18, 2005
<TABLE> <S> <C>


<ARTICLE>                     5
<MULTIPLIER>                                     1,000

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                             792
<SECURITIES>                                         0
<RECEIVABLES>                                    9,105
<ALLOWANCES>                                       650
<INVENTORY>                                      9,310
<CURRENT-ASSETS>                                20,097
<PP&E>                                           9,788
<DEPRECIATION>                                   5,951
<TOTAL-ASSETS>                                  43,878
<CURRENT-LIABILITIES>                           11,360
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                             7
<OTHER-SE>                                      30,788
<TOTAL-LIABILITY-AND-EQUITY>                    43,878
<SALES>                                         58,487
<TOTAL-REVENUES>                                58,487
<CGS>                                           28,394
<TOTAL-COSTS>                                   28,394
<OTHER-EXPENSES>                                24,597
<LOSS-PROVISION>                                   290
<INTEREST-EXPENSE>                                 208
<INCOME-PRETAX>                                  4,937
<INCOME-TAX>                                     1,437
<INCOME-CONTINUING>                              3,500
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                     3,500
<EPS-BASIC>                                       0.52
<EPS-DILUTED>                                     0.45



</TABLE>
<page>

EXHIBIT 32.2

                  CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER
                                   PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

       In connection with the Quarterly Report of VOYAGER PETROLEUM, INC. (the
"Company") on Form 10-QSB/A for the period ended September 30, 2007 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"),
I, Cathy A. Persin, Chief Financial Officer of the Company, certify, pursuant to
18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002, that:

       (1)    The Report fully complies with the requirements of section 13(a)
              or 15(d) of the Securities Exchange Act of 1934; and

       (2)    The information contained in the Report fairly presents, in all
              material respects, the financial condition and results of
              operations of the Company.



Date: October 8, 2008                     By: /s/ Cathy A. Persin
                                             -----------------------------------
                                             Principal Financial Officer
#### The People of the State of New York, Respondent, v William Bryant, Appellant.

— Judgment unanimously affirmed. Memorandum: There is no merit to defendant’s contention that evidence obtained as a result of an eavesdropping warrant should have been suppressed. In reviewing the application for an eavesdropping warrant, the People’s showing must be reviewed in a practical and common sense, not hypertechnical, fashion in the context of the subject investigation *(see, People v Hafner,*152 AD2d 961, 962; *People v Campaigni,*151 AD2d 1010, *lv denied*74 NY2d 845; *People v Baris,*116 AD2d 174, 187, *lv denied*67 NY2d 1050; *People v Gallina, 95*AD2d 336, 340). In the circumstances of this case, we find that the People adequately established that there was probable cause for the warrant and that normal investigative techniques were unavailing *(see, People v Bachiller,*159 AD2d 955, *lv denied*76 NY2d 784; *see also,*CPL 700.15).

We have examined defendant’s other contention and find it to be without merit. (Appeal from Judgment of Monroe County Court, Connell, J. — Conspiracy, 2nd Degree.) Present— Denman, J. P., Boomer, Lawton, Lowery and Davis, JJ.
[Federal Register Volume 88, Number 248 (Thursday, December 28, 2023)]
[Notices]
[Page 89721]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-28678]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meeting

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; R13 Conference Grant 
Applications.
    Date: February 22, 2024.
    Time: 10:00 a.m. to 1:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, NIDDK Democracy II, Suite 
7000A, 6707 Democracy Boulevard, Bethesda, MD 20892 (Virtual 
Meeting).
    Contact Person: Jian Yang, Ph.D., Scientific Review Officer, 
Review Branch, Division of Extramural Activities, NIDDK, National 
Institutes of Health, Room 7111, 6707 Democracy Boulevard, Bethesda, 
MD 20892-5452, (301) 594-7799, <a href="/cdn-cgi/l/email-protection#f28b939c9598b2978a868093dc9c9b969699dc9c9b9adc959d84"><span class="__cf_email__" data-cfemail="aed7cfc0c9c4eecbd6dadccf80c0c7cacac580c0c7c680c9c1d8">[email protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)

    Dated: December 22, 2023.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2023-28678 Filed 12-27-23; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
# Catoosa - Appalachian Regional Commission

- Northwest Georgia Regional Commission Executive Director Boyd Austin Email &#x62;&#x61;&#117;&#115;t&#x69;&#x6e;&#x40;&#110;&#119;g&#x72;&#x63;&#x2e;&#111;&#114;gThe post Northwest Georgia Regional Commission appeared first on Appalachian Regional Commission.
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA
F OURTH D ISTRICT

RAYMOND GREEN , Appellant,

v.

STATE OF FLORIDA , Appellee.

No. 4D 19

- 2718

[ June 4, 2020 ]

Appeal from the Circuit Court for the Fift eenth Judicial Circuit, Palm Beach County ; Cymonie S. Rowe , Judge; L.T. Case No. 50

- 2019

- CA

008587

- AXXX

- MB

.

Thomas J. Gruseck , West Palm Beach, for appellant

.
Ashley Moody, Attorney General, Tallahassee, and Lindsay A. Warner, Assistant Attorney General, West Palm Beach, for appellee.

P ER C URIAM

.
Affirmed.

D AMOORGIAN , F ORST and K LINGENSMITH , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.